After an evaluation process of the inoculation against him covid-19 in the country, the Ministry of Public Health (MSP) reported several Events Supposedly Attributable to Vaccination and Immunization (ESAVI).
This term is known as signs, abnormal findings, symptom or unfavorable and unintentional diseases that occur after vaccination and immunization and that do not necessarily have a causal relationship with it, says the Ministry of Health.
In this framework, the State Portfolio formed a Serious ESAVI National Advisory Commissionin order to determine if there is a causal relationship between vaccination and the event presented.
The Vice Minister of Governance and Health Surveillance, Joseph Rualessaid on April 13, 2022 that the commission is made up of experts independent in neurology, pediatrics, internal medicine, vaccine-preventable diseases, microbiology who have been studying serious ESAVI.
He added that this commission has the support of technicians from the National Agency for Sanitary Regulation, Control and Surveillance (Arcsa), the MSP and the Pan American Health Organization / World Health Organization (PAHO/WHO).
0.9 cases per 10 million doses presented severe ESAVI
In a period between January 2021 and March 12, 2022, the MSP has collected 3,582 notifications of a total of 32.6 million doses applied in the country.
Of the total number of notifications, 3,496 are non-serious ESAVIthat is, those that do not put the person’s life at risk, which represents a frequency of 10.71 cases per 100,000 doses administered.
The Ministry details that the remaining 86 are probable serious events (0.26 cases per 100,000 doses), of which, so far, three have been identified as being related to the vaccine (0.9 cases per 10 million doses).
The others are mostly coincidental or indeterminate events. In addition, up to the date of the report, no deaths have been registered as a result of the vaccine.
As for the non-serious ESAVIindicates the MSP, it is determined that the majority of cases are concentrated in the groups of 18 to 44 years, followed by 45 to 64, 65 to 74, under 18 and over 75.
Los symptom what prevail son fever (22,41%), headache o headaches (15.52%), malaise (13.79%), pain at the puncture site (10.34%), nausea (6.90%), dizziness (5.17%), fatigue (5.17%), skin flushing (5.17%) and diarrhea (5.17%).
Los ESAVI seriousOn the other hand, they present low figures. Of the 86 reported, 58 are in the group of 18 to 64 years. Then there are adolescents from 12 to 17, older than 65 and from 3 to 11 years.
Of the total, only three are related to the covid-19 vaccine. They were detected allergic reaction, Thrombosis Syndrome due to thrombocytopenia and others, mentions the information.
In the statement, the MSP emphasizes that serious ESAVI rates are within expectations and are similar to those reported in other countries in the region and the world.
The Minister of Health, Ximena Garzón, explained that the serious ESAVIs, especially the thrombosis, does not occur frequently. “It’s a very rare thing,” she said.
–
